Concepedia

Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma

Ryusei Matsuyama, Yohei Ota, Yuki Homma, Yasuhiro Yabusita, Seigo Hiratani, Takashi Murakami, Yu Sawada, Kentaro Miyake, Yasuhiro Shimizu, Takafumi Kumamoto,

Annals of Surgical Oncology · 2022 · 22 citations · 45 references

DOI

Concepts

References

45

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

Juan W. Valle, Harpreet Wasan, Daniel H. Palmer et al. · New England Journal of Medicine · 2010 · 4.4K citations · Full text

, , +12

Japanese Classification of Gastric Carcinoma – 2nd English Edition –

Gastric Cancer · 1998 · 2.2K citations · Full text

, , +16

Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer

Helmut Oettle, P. Neuhaus, Andreas Hochhaus et al. · JAMA · 2013 · 1.8K citations

, , +16

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

Richard Fox, Daniel H. Palmer, Hassan Malik et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

, , +9

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

Katsuhiko Uesaka, Narikazu Boku, Akira Fukutomi et al. · The Lancet · 2016 · 1.1K citations

, , +7